COMMUNIQUÉS West-GlobeNewswire

Announcement from Acarix's annual general meeting
20/05/2019
Press release Malmö, May 20, 2019 Announcement from Acarix's annual general meeting The annual general meeting (" AGM ") of Acarix AB (" Acarix " or the " Company ") was held today on 16 May 2019 and the following [...]
Addex Increases Issued Share Capital and Creates Treasury Shares
20/05/2019
Geneva, Switzerland, May 20, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, today announced that it has increased its capital from 28,564, [...]
The US Department of Defense and Deinove will present impactful R&D results during the coming ASM 2019
20/05/2019
L’USAMRIID (United States Army Medical Research Institute of Infectious Diseases) evaluated DNV3681 against Bacillus anthracis that triggers anthrax and Francisella tularensis that triggers tularemia or rabbit fever, [...]
ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
19/05/2019
Amsterdam, The Netherlands – 19 May 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has received a notice from Euronext that its ordinary shares will be transferred to trading group JG, a special [...]
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
19/05/2019
IBT has for an extended time consulted with the US Food and Drug Administration (FDA) on how the company's planned Phase III study should be designed. The FDA has now informed IBT in writing that IBT has responded [...]
Following Charles Barkley’s On-Air Suggestion, The Toe Bro Rolls Cordially Invites NBA Hall of Famer and Legend Shaquille O’Neal for a Free Foot Consultation in Toronto
19/05/2019
TORONTO, May 19, 2019 (GLOBE NEWSWIRE) -- The Toe Bro, an internationally sought-after foot specialist (Chiropodist) and star of the A&E series The Toe Bro , cordially invites Shaquille O’Neal – affectionately named [...]
New Report Shows CRC Screening Rates Increased When a Medically Underserved Population is Offered Epi proColon® Blood Test
19/05/2019
– Data Presented at DDW 2019 Show 93.6% Acceptance Rate Among Patients Unwilling or Unable to Complete Other CRC Screening Tests – BERLIN and SAN DIEGO, May 19, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (FSE: ECX, OTCQX: [...]
National Lipid Association (NLA) and the Foundation of the NLA Honors Renowned Cardiologist Dr. Vera Bittner with Distinguished Achievement Award
18/05/2019
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) and the Foundation of the NLA have selected Vera A. Bittner, MD, MSPH, FNLA as the recipient of the 2019 W. Virgil Brown Distinguished [...]
Mount Sinai Icahn School of Medicine’s Dr. Robert S. Rosenson Receives Foundation of the National Lipid Association 2019 Clinician/Educator Award
18/05/2019
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- Robert S. Rosenson, MD, FACC, FACP, FAHA, FESC, FNLA, FACCP, Professor of Medicine and Director of Cardiometabolic Disorders at the Icahn School of Medicine at Mt. Sinai, is the [...]
Ambu A/S: Cook Medical and Ambu announce collaboration to address endoscope-related infections
18/05/2019
Cook Medical and Ambu A/S have agreed on terms to enter into a partnership under which Cook will distribute Ambu’s single-use, disposable duodenoscope in the U.S., following FDA clearance. The scope is currently being [...]
New Data Presented at DDW 2019 Demonstrate That WATS3D Provides Clinical Benefit in Detecting Residual/Recurrent Intestinal Metaplasia in Post-Barrett’s Esophagus Ablation Patients
18/05/2019
- Study shows that the addition of WATS 3D increased the detection of residual/recurrent intestinal metaplasia by 79% and associated dysplasia by 224% - SUFFERN, N.Y., May 18, 2019 (GLOBE NEWSWIRE) -- CDx Diagnostics [...]
Medcolcanna and Integrated Energy Storage Complete Business Combination
18/05/2019
TSX-V has provided conditional approval to listing - Shares expected to commence trading May 23, 2019 under the symbol “MCCN” Notice: Not for distribution to the United States newswire services or for release, [...]
MRI Interventions Announces Closing of $7.522 Million Private Placement
17/05/2019
IRVINE, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) today announced the closing on May 17, 2019 of its previously disclosed private placement of shares of common stock, which resulted [...]
Tonix Pharmaceuticals Announces Director Stepping Down
17/05/2019
NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced that Donald W. Landry, M.D., Ph.D., is stepping down from the Company’s Board of Directors, effective May [...]
Obalon Announces Receipt of Delisting Notification Letters from Nasdaq
17/05/2019
SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Statin Use Survey Among the First to Highlight Importance of Adverse Patient Experiences in Discontinuing Medication Use
17/05/2019
MIAMI, May 17, 2019 (GLOBE NEWSWIRE) -- Findings of the first patient statin use survey based on a comprehensive set of patient experiences and behavioral markers were presented today at the National Lipid Association’s [...]
National Lipid Association Announces Designation for Experts in Clinical Lipidology
17/05/2019
Newly Defined Term Lipid Specialist Aims to Formalize Medical Specialty, Enhance Public Understanding of Blood Fat Disorders and Optimal Treatment MIAMI, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- With the Centers for [...]
National Lipid Association Releases Official Scientific Statement Regarding Use of Lipoprotein(a) in Clinical Practice
17/05/2019
JACKSONVILLE, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of an official scientific statement on Lipoprotein(a) [Lp(a)] clinical use at the NLA 2019 Scientific [...]
Abeona Therapeutics annonce ses résultats financiers et expose les faits marquants du premier trimestre 2019
17/05/2019
Achèvement des travaux de CMC préalablement à l'essai de phase 3 VITAL™ pour EB-101 qui devrait débuter mi-2019 Dépôt d'une demande de DNR pour ABO-202 dans la maladie CLN1 Conférence téléphonique avec les investisseurs [...]

Pages